All Pharma News
Vicore`s IPF drug improves lung function in phase 2 win

Vicore`s IPF drug improves lung function in phase 2 win
James Waldron FIERCE BIOTECH
20 May 2024
Share Share
Vicore doses first patient in trial of endothelial dysfunction

Vicore doses first patient in trial of endothelial dysfunction
CLINICAL TRIALS ARENA
05 May 2023
Share Share
Vicore begins vital endothelial dysfunction study

Vicore begins vital endothelial dysfunction study
John Pinching PHARMATIMES
04 May 2023
Share Share
Vicore initiates clinical proof-of-concept study of endothelial dysfunction

Vicore initiates clinical proof-of-concept study of endothelial dysfunction
BUSINESSWIRE
03 May 2023
Share Share
Vicore announces first patient enrolled in COMPANION;a digital therapeutic study

Vicore announces first patient enrolled in COMPANION;a digital therapeutic study
PRNEWSWIRE
05 Dec 2022
Share Share
Vicore announces new data from IPF AIR trial further strengthening the benefit

Vicore announces new data from IPF AIR trial further strengthening the benefit
CISION
03 Nov 2022
Share Share
Vicore`s digital therapeutic shows nearly 50% anxiety reduction in pilot study

Vicore`s digital therapeutic shows nearly 50% anxiety reduction in pilot study
PRNEWSWIRE
06 Oct 2022
Share Share
Vicore announces that C21 promotes vascular function in humans

Vicore announces that C21 promotes vascular function in humans
PRNEWSWIRE
22 Sep 2022
Share Share
Vicore IPF interim data selected as an oral

Vicore IPF interim data selected as an oral "late-breaker" at the ERS congress
PRNEWSWIRE
17 Aug 2022
Share Share
Vicore announces first human dosed with novel ATRAG, C106

Vicore announces first human dosed with novel ATRAG, C106
PRNEWSWIRE
16 Jun 2022
Share Share